Every trainee reporter Kim Yofa from Guangzhou Beijing Tong Ren Tang Technology Development Co., Ltd. (hereinafter referred to Tang Ren Tong Technology; 01666,hk) A drug in Hong Kong is suffering a quality storm. May 7, the Hong Kong Special Administrative Region Government Department of Health announced that the five-pill mercury (Mercury) content in the Tong Ren Tong, produced by Beijing Tong Ren Tang Technology Development Co., is about 5 times times higher than the maximum standard, and the instructions are recycled. Yesterday (May 8), Tongren Ren Tong Technology Securities Department staff to the "Daily economic news" Reporter said that the batch of products do not belong to the Tong Ren Tong Technology, the company is investigating the source of products. It is understood that due to differences in the standards of Chinese medicine monitoring in Hong Kong and the mainland, in recent years, Chinese medicines produced in the mainland have repeatedly been found to be excessive heavy metals. 5 times times the amount of mercury exposed. In the official website of the Hong Kong Special Administrative Region Government Department of Health, the Department of Health has instructed a licensed Chinese patent medicine wholesaler Beijing Tongren Tong Tong Hong Kong Pharmaceutical Management Limited to recover from the market a group of five pills (registration number: HKP-08760, Batch No.: 1033946) Proprietary Chinese medicine, as the mercury content of the batch product was found to exceed the ceiling standard. A spokesman for the Hong Kong Department of Health said that the order was withdrawn after the Department of Health (DH) had purchased the sample from the government laboratory after buying a five-pill for the Tong Ren Tong from market monitoring, and the result showed that the mercury content of the proprietary Chinese Medicine sample was about 5 times times the maximum standard. So far no reports of discomfort have been received. "Acute mercury poisoning can cause inflammation in the mouth, such as prolonged ingestion of mercury, which can cause damage to the nervous system and kidneys," he said. The announcement also clearly released a picture of the fitness five-pill. Reporter in the product below see, the manufacturer is Beijing Tongren Tong Tong Technology Development Co., Ltd. Pharmaceutical factory, the total distribution is Beijing Tongren Tong Ren Hong Kong Pharmaceutical Management Co. Yesterday, "Daily economic news" reporter called the Tong Ren Tong Technology Securities department. Staff said that the company did not produce the involved batches of products, is currently investigating the source of products. "At present, there is only a Tong Ren Tong technology A healthy five-pill production batch number, after the production of drugs in Hong. The company is now aware of the reasons why there are drugs that are not produced in our market. The staff also pointed out that the company produced products in strict accordance with national standards of production, the quality indicators are in line with the 2010 version of the Chinese Pharmacopoeia standard, while the fitness of five pills is not a hot-selling products in the company's revenue accounted for smaller. or due to different standards? An industry insider told reporters that the mercury content is highly likely to be by the fitness of five pills in winter cordyceps ingredients caused. "Some unscrupulous traders in order to increase the weight of cordyceps, will be doped with Mercury." This batch of products may use this kind of inferior cordyceps sinensis, and lead to excessive mercury content. In fact, this is not the first time that the Hong Kong Department of Health has challenged the mainland's drug mercury standard. "Daily economic news" reporter learned that last March, Wuhan, China Union Pharmaceutical Group Co., Ltd. production of "Gu" brand of the nerves of the soothing brain tablets due to mercury content exceeded 55 times times by the Hong Kong Department of Health request recovery; In October, Hong KongThe Department of Health instructed Beijing Pharmaceutical factory to recover 9 white Phoenix pills contaminated with mercury and other proprietary Chinese medicines using the same batch of raw materials. Why are Chinese medicines produced in the mainland frequently prosecuted in Hong Kong for excessive heavy metal content? CIC Consultant Medicine Industry researcher Guofan pointed out that this is due to the difference between the two places on the use of proprietary Chinese Medicine limited standards. It is understood that the mainland's Chinese proprietary Chinese Medicine monitoring standards mainly refer to "China Pharmacopoeia", and Hong Kong's heavy metal monitoring standards are based on Hong Kong's existing "Chinese Medicine Ordinance" mainly, relatively speaking, the latter standard more stringent.
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.